SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
STRATEGIES FOR HIV CURE
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
TARGETING THE NONCANONICAL NF-ΚB PATHWAY REVERSES SIV LATENCY (ABSTRACT
22)
Maud Mavigner
Emory University School of Medicine, Atlanta, GA, USA
NONSUPPRESSIBLE VIREMIA ON ART FROM LARGE CELL CLONES CARRYING INTACT PROVIRUSES (ABSTRACT
23)
Elias K Halvas
University of Pittsburgh, Pittsburgh, PA, USA
EX VIVO AND IN VIVO EDITING OF THE SIV GENOME IN NONHUMAN PRIMATES BY CRISPR-CAS9 (ABSTRACT
24)
Tricia H. Burdo
Temple University School of Medicine, Philadelphia, PA, USA
DELAYED VIRAL REBOUND DURING ATI AFTER INFUSION OF CCR5 ZFN-TREATED CD4 T CELLS (ABSTRACT
25)
Pablo Tebas
University of Pennsylvania, Philadelphia, PA, USA
MULTIDOSE IV ROMIDEPSIN: NO INCREASED HIV-1 EXPRESSION IN PERSONS ON ART, ACTG A5315 (ABSTRACT
26)
Deborah McMahon
University of Pittsburgh, Pittsburgh, PA, USA
PEMBROLIZUMAB INDUCES HIV LATENCY REVERSAL IN HIV+ INDIVIDUALS ON ART WITH CANCER (ABSTRACT
27)
Thomas S Uldrick
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
POTENT ANTIVIRAL ACTIVITY OF TRISPECIFIC BROADLY NEUTRALIZING HIV ANTIBODIES (ABSTRACT
28)
Amarendra Pegu
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
SUSTAINED HIV-1 REMISSION FOLLOWING HOMOZYGOUS CCR5 DELTA32 ALLOGENIC HSCT (ABSTRACT
29)
Ravindra K Gupta
University College London, London, United Kingdom
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
